These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 22745759)

  • 1. Effects of hyperuricemia on renal function of renal transplant recipients: a systematic review and meta-analysis of cohort studies.
    Huang Y; Li YL; Huang H; Wang L; Yuan WM; Li J
    PLoS One; 2012; 7(6):e39457. PubMed ID: 22745759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperuricemia and risk of incident hypertension: a systematic review and meta-analysis of observational studies.
    Wang J; Qin T; Chen J; Li Y; Wang L; Huang H; Li J
    PLoS One; 2014; 9(12):e114259. PubMed ID: 25437867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis.
    Sharma G; Dubey A; Nolkha N; Singh JA
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211016661. PubMed ID: 34104231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of hyperuricemia on long-term clinical outcomes of renal transplant recipients: a systematic review and meta-analysis.
    Yang H; Chen Q; Huang A; Yu X; Chen G; Hu X; Wang W; Liu H; Zhang X; Liu L
    J Pharm Pharm Sci; 2021; 24():292-307. PubMed ID: 34107240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperuricemia and contrast-induced acute kidney injury: A systematic review and meta-analysis.
    Zuo T; Jiang L; Mao S; Liu X; Yin X; Guo L
    Int J Cardiol; 2016 Dec; 224():286-294. PubMed ID: 27665399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of hyperuricemia on renal function in pediatric renal transplant recipients.
    Fidan C; Kantar A; Baskın E; Gülleroğlu K; Akdur A; Moray G; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():247-50. PubMed ID: 25894164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.
    Sampson AL; Singer RF; Walters GD
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009460. PubMed ID: 29084343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
    Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
    Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients.
    Karbowska A; Boratynska M; Kusztal M; Klinger M
    Transplant Proc; 2009 Oct; 41(8):3052-5. PubMed ID: 19857674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The correlation between uric acid and the incidence and prognosis of kidney diseases: a systematic review and meta-analysis of cohort studies].
    Li YL; Wang L; Li J; Huang Y; Yuan WM
    Zhonghua Nei Ke Za Zhi; 2011 Jul; 50(7):555-61. PubMed ID: 22041264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
    Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
    Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and risk factors of hyperuricemia among kidney transplant recipients.
    Einollahi B; Einollahi H; Nafar M; Rostami Z
    Indian J Nephrol; 2013 May; 23(3):201-5. PubMed ID: 23814419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperuricemia and the Prognosis of Hypertensive Patients: A Systematic Review and Meta-Analysis.
    Qin T; Zhou X; Wang J; Wu X; Li Y; Wang L; Huang H; Li J
    J Clin Hypertens (Greenwich); 2016 Dec; 18(12):1268-1278. PubMed ID: 27247021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of uric acid-lowering therapy on the progression of chronic kidney disease: a systematic review and meta-analysis.
    Liu X; Zhai T; Ma R; Luo C; Wang H; Liu L
    Ren Fail; 2018 Nov; 40(1):289-297. PubMed ID: 29619870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of febuxostat for treating hyperuricemia in patients with chronic kidney disease and in renal transplant recipients: A systematic review and meta-analysis.
    Liu X; Liu K; Sun Q; Wang Y; Meng J; Xu Z; Shi Z
    Exp Ther Med; 2018 Sep; 16(3):1859-1865. PubMed ID: 30186411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uric acid and transplantation.
    Mazali FC; Mazzali M
    Semin Nephrol; 2011 Sep; 31(5):466-71. PubMed ID: 22000655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of febuxostat for treatment of asymptomatic hyperuricemia among kidney transplant patients: A meta-analysis of observational studies.
    Chewcharat A; Chang YT; Thongprayoon C; Crisafio A; Bathini T; Mao MA; Cheungpasitporn W
    Clin Transplant; 2020 Apr; 34(4):e13820. PubMed ID: 32034944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperuricemia in pediatric renal transplant recipients.
    Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A
    Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperuricemia predicts kidney disease progression after acute allograft dysfunction.
    Weng SC; Shu KH; Wu MJ; Cheng CH; Chen CH; Yu TM; Chuang YW; Huang ST; Tarng DC
    Transplant Proc; 2014; 46(2):499-504. PubMed ID: 24655999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of uric acid with inflammation, progressive renal allograft dysfunction and post-transplant cardiovascular risk.
    Bandukwala F; Huang M; Zaltzman JS; Nash MM; Prasad GV
    Am J Cardiol; 2009 Mar; 103(6):867-71. PubMed ID: 19268747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.